Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department is taking to improve the quality of care provided for people with incontinence in the UK.
Answered by Jane Ellison
NHS England has advised that according to a survey conducted in 2008, there are over 14 million adults who have bladder control problems and 6.5 million with bowel control problems in the United Kingdom.
The Department does not collect information on the number of people living with urinary and faecal incontinence specific to Northern Ireland, Scotland and Wales. This is a matter for devolved administrations.
The Healthcare Quality and Improvement Partnership (2010) established that in order to achieve the best clinical outcomes, continence services have to be integrated across primary and secondary care and care home settings.
They also concluded that ‘there is an urgent need for improved and equitable practice for all people with bladder and bowel problems’ through the development of commissioning frameworks, evidence-based training for health professionals and patient empowerment to increase their expectations of cure.
Improving continence care provision through integrated services brings many benefits including:
- a better quality of life and more independence through finding solutions appropriate to individual needs;
- less reliance on pads and products by using alternative treatments;
- a reduction in admissions to hospitals and care homes;
- fewer complications, such as urinary tract infections, faecal impaction and skin breakdown; and
- a reduction in costs.
NHS England’s Excellence in Continence Care guidance provides a framework that enables commissioners to work in collaboration with providers and others to make a step change to address shortfalls so that safe, dignified, efficient and effective continence care is consistently provided.
This guidance is aimed at commissioners, providers, health and social care staff and as information for the public and has been produced in partnership with patient and public advocates, clinicians and partners from the third sector. The roles of everyone involved in the care of people with continence needs are made clear in the guidance and publication via a launch is planned for ‘Self Care Week’ beginning 16 November. The launch will both raise awareness and promote understanding.
In addition the National Institute for Health and Care Excellence has produced a range of guidance for clinicians to support them in the diagnosis, treatment care and support and people with continence problems e.g. Urinary incontinence in women (September 2013), Faecal incontinence in adults (June 2007), Urinary incontinence in neurological disease: assessment and management (August 2012) and Lower urinary tract symptoms in men: management (May 2010).
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what progress his Department has made on raising awareness and promoting understanding of incontinence amongst (a) health and social care staff and (b) the general public; and if he will make a statement.
Answered by Jane Ellison
NHS England has advised that according to a survey conducted in 2008, there are over 14 million adults who have bladder control problems and 6.5 million with bowel control problems in the United Kingdom.
The Department does not collect information on the number of people living with urinary and faecal incontinence specific to Northern Ireland, Scotland and Wales. This is a matter for devolved administrations.
The Healthcare Quality and Improvement Partnership (2010) established that in order to achieve the best clinical outcomes, continence services have to be integrated across primary and secondary care and care home settings.
They also concluded that ‘there is an urgent need for improved and equitable practice for all people with bladder and bowel problems’ through the development of commissioning frameworks, evidence-based training for health professionals and patient empowerment to increase their expectations of cure.
Improving continence care provision through integrated services brings many benefits including:
- a better quality of life and more independence through finding solutions appropriate to individual needs;
- less reliance on pads and products by using alternative treatments;
- a reduction in admissions to hospitals and care homes;
- fewer complications, such as urinary tract infections, faecal impaction and skin breakdown; and
- a reduction in costs.
NHS England’s Excellence in Continence Care guidance provides a framework that enables commissioners to work in collaboration with providers and others to make a step change to address shortfalls so that safe, dignified, efficient and effective continence care is consistently provided.
This guidance is aimed at commissioners, providers, health and social care staff and as information for the public and has been produced in partnership with patient and public advocates, clinicians and partners from the third sector. The roles of everyone involved in the care of people with continence needs are made clear in the guidance and publication via a launch is planned for ‘Self Care Week’ beginning 16 November. The launch will both raise awareness and promote understanding.
In addition the National Institute for Health and Care Excellence has produced a range of guidance for clinicians to support them in the diagnosis, treatment care and support and people with continence problems e.g. Urinary incontinence in women (September 2013), Faecal incontinence in adults (June 2007), Urinary incontinence in neurological disease: assessment and management (August 2012) and Lower urinary tract symptoms in men: management (May 2010).
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate his Department has made of the number of people living with (a) urinary incontinence and (b) faecal incontinence in (i) Northern Ireland, (ii) Scotland and (iii) Wales.
Answered by Jane Ellison
NHS England has advised that according to a survey conducted in 2008, there are over 14 million adults who have bladder control problems and 6.5 million with bowel control problems in the United Kingdom.
The Department does not collect information on the number of people living with urinary and faecal incontinence specific to Northern Ireland, Scotland and Wales. This is a matter for devolved administrations.
The Healthcare Quality and Improvement Partnership (2010) established that in order to achieve the best clinical outcomes, continence services have to be integrated across primary and secondary care and care home settings.
They also concluded that ‘there is an urgent need for improved and equitable practice for all people with bladder and bowel problems’ through the development of commissioning frameworks, evidence-based training for health professionals and patient empowerment to increase their expectations of cure.
Improving continence care provision through integrated services brings many benefits including:
- a better quality of life and more independence through finding solutions appropriate to individual needs;
- less reliance on pads and products by using alternative treatments;
- a reduction in admissions to hospitals and care homes;
- fewer complications, such as urinary tract infections, faecal impaction and skin breakdown; and
- a reduction in costs.
NHS England’s Excellence in Continence Care guidance provides a framework that enables commissioners to work in collaboration with providers and others to make a step change to address shortfalls so that safe, dignified, efficient and effective continence care is consistently provided.
This guidance is aimed at commissioners, providers, health and social care staff and as information for the public and has been produced in partnership with patient and public advocates, clinicians and partners from the third sector. The roles of everyone involved in the care of people with continence needs are made clear in the guidance and publication via a launch is planned for ‘Self Care Week’ beginning 16 November. The launch will both raise awareness and promote understanding.
In addition the National Institute for Health and Care Excellence has produced a range of guidance for clinicians to support them in the diagnosis, treatment care and support and people with continence problems e.g. Urinary incontinence in women (September 2013), Faecal incontinence in adults (June 2007), Urinary incontinence in neurological disease: assessment and management (August 2012) and Lower urinary tract symptoms in men: management (May 2010).
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question
To ask the hon. Member for Mole Valley representing the House of Commons Commission, where defibrillator units are located on the Parliamentary Estate; and how often they are serviced to ensure they are working.
Answered by Paul Beresford
There are 18 Defibrillators across the Parliamentary estate in the following locations:
Palace of Westminster
7 Millbank
Millbank House
6/7 Old Palace Yard
Norman Shaw North
Canon Row
14 Tothill Street
Portcullis House
Defibrillators are checked weekly to ensure that they are working, and receive a full service annually.
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Northern Ireland Office:
To ask the Secretary of State for Northern Ireland, what steps she is taking to increase the sustainability of the Northern Ireland Executive's finances.
Answered by Theresa Villiers
Under the Stormont House Agreement, the Government provided £2billion of additional spending power to help deal with problems which are specific to Northern Ireland such as addressing the legacy of its past.
This is in addition to the block grant and extra security funding of £231million.
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department for International Development:
To ask the Secretary of State for International Development, what priority she gives to promoting economic development in countries which receive UK aid.
Answered by Desmond Swayne
Economic development is the only way we can ultimately defeat poverty. No country has been able to eradicate poverty without sustainable growth. Our work in this economic development is and will remain one of our highest priority areas over the next five years.
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question
To ask the Secretary of State for Energy and Climate Change, what amount the National Grid is expected to spend on (a) preparatory, (b) consultancy, (c) construction and (d) all other costs for connecting wind farms in mid-Wales with the grid in North Shropshire.
Answered by Matt Hancock
National Grid’s proposals for the Mid-Wales connection are still in development, but it currently estimates that the new connection may cost £360m to £400m. National Grid’s costs are regulated by Ofgem to ensure they are justified and efficient.
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question
To ask the hon. Member for Caithness, Sutherland and Easter Ross representing the House of Commons Commission, what proportion of the meat served in Parliament's restaurants in the last year had been sourced from animals slaughtered by non-stun methods.
Answered by Viscount Thurso
House of Commons catering services do not purchase or serve any meat from animals slaughtered by non-stunned methods. House of Lords restaurants are a matter for that House; however, I understand that it takes a similar approach.
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment his Department has made of the effectiveness of the Anti-PD-L1 drug in treating bladder cancer.
Answered by George Freeman
Two Anti-PD monoclonal antibody products are being evaluated in clinical trials for various cancers, including bladder cancer.
MPDL3280A, an anti-PD-L1 antibody made by Roche/Genentech, is undergoing a phase I trial (NCT01375842) in patients with locally advanced or metastatic solid tumours. The estimated study completion date is November 2016. The product is also being tested in a phase II trial in in patients with locally advanced or metastatic urothelial bladder cancer (NCT02108652). The estimated completion date for this Phase II trial is January 2016.
The second anti-PD antibody is Nivolumab produced by Bristol-Myers Squibb. Nivolumab on its own, or in combination with another monoclonal antibody ipilimumab (Yervoy®), is in a phase I/II trial in several cancers, including bladder cancer (NCT01928394). This trial is expected to be completed by March 2017.
No assessment of the data from any of these trials has been made to date.
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps he is taking to promote awareness of bladder cancer to people under the age of 55.
Answered by Jane Ellison
Public Health England’s Be Clear on Cancer “Blood in Pee” campaign to raise awareness of the main symptom of bladder and kidney cancer targets people over the age of 50, as both of these cancers are more prevalent in people over that age. The campaign uses a wide range of media, including national television and radio advertising, to promote the key message “If you notice blood in your pee, even if it’s just the once, tell your doctor” and while this is targeted to an audience aged 50+ it is very likely that it will also be seen by the wider population.
The “Blood in Pee” campaign has run twice at a national level, following successful local and regional pilots. The national campaign ran in October – November 2013 and October – November 2014.